Stoke Therapeutics CEO Edward Kaye's 2022 pay falls 33% to $5.7M
Stoke Therapeutics reports 2022 executive compensation
By ExecPay News
Published: September 28, 2023
Stoke Therapeutics reported fiscal year 2022 executive compensation information on September 28, 2023.
In 2022, three executives at Stoke Therapeutics received on average a compensation package of $3.5M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Stoke Therapeutics
Edward M. Kaye, Chief Executive Officer, received $5.7M in total, which decreased by 33% compared to 2021. 84% of Kaye's compensation, or $4.8M, was in option awards. Kaye also received $32K in bonus, $291K in non-equity incentive plan, $596K in salary, as well as $12K in other compensation.
Barry S. Ticho, Chief Medical Officer, received a compensation package of $2.4M, which decreased by 24% compared to previous year. 71% of the compensation package, or $1.7M, was in option awards.
Stephen J. Tulipano, Chief Financial Officer, earned $2.3M in 2022, a 25% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 28, 2023.